OSE IMMUNOTHERAPEUTICS

Analyst Reco. OSE Immunotherapeutics

Equities

OSE

FR0012127173

Market Closed - Euronext Paris Other stock markets 11:38:58 2024-05-10 am EDT			5-day change	1st Jan Change
6.75 ^EUR	-3.57%		+8.87%	+57.71%

Apr. 17	OSE: licensing agreement with AbbVie enters into force	CF
Apr. 17	OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OSE IMMUNOTHERAPEUTICS : Degroof Petercam reiterates buy recommendation	Mar. 18	CF
OSE IMMUNO : Oddo BHF confirms its recommendation	23-07-06	CF
OSE IMMUNO : Invest Securities confirms its recommendation	23-07-06	CF
OSE IMMUNO : Invest Securities confirms its recommendation	23-06-27	CF
Ose Immuno: share price falls, broker lowers target	23-05-16	CF
OSE IMMUNO : Invest Securities lowers its target	23-05-16	CF
TODAY'S ANALYST RECOMMENDATIONS : Barclays, Ford, Microsoft, Oracle, Lloyds...	21-05-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW